These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 4627828)

  • 1. [Morpho-functional changes in the pyramidal and extrapyramidal systems due to triftazin].
    Krivitskaia GN; Sysoeva AF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(7):1063-8. PubMed ID: 4627828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transitory exacerbations arising during the course of neuroleptic therapy].
    Gurovich IIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute extrapyramidal reaction to trifluoperazine dihydrochloride.
    Bajpai PC; Pathak AK; Sethi VK; Bhargava KP
    J Indian Med Assoc; 1969 Oct; 53(7):350-1. PubMed ID: 5368375
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-induced extrapyramidal disorders.
    Chase TN
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():448-71. PubMed ID: 4341954
    [No Abstract]   [Full Text] [Related]  

  • 5. Taste sensitivity and the appearance of phenothiazine-tranquilizer induced extrapyramidal symptoms.
    Fischer R; Knopp W; Griffin F
    Arzneimittelforschung; 1965 Dec; 15(12):1379-82. PubMed ID: 5899813
    [No Abstract]   [Full Text] [Related]  

  • 6. [Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics].
    Berchtold P; Hinssen M; Irmscher K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):420-1. PubMed ID: 4151333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M
    Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of individual tolerance, behavior and phenothiazine produced extrapyramidal system disturbance.
    Simpson GM; Kunz-Bartholini E
    Dis Nerv Syst; 1968 Apr; 29(4):269-74. PubMed ID: 5652493
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phenomenology of the most important pyramidal and extrapyramidal motoric syndromes. Indications for surgery and results. I].
    Mundinger F
    Z Allgemeinmed; 1974 Jun; 50(18):827-37. PubMed ID: 4277897
    [No Abstract]   [Full Text] [Related]  

  • 10. [Extrapyramidal syndrome induced by trifluoperazine in a pharmaceutical industry worker].
    Farina G; Sbertoli C
    Med Lav; 1969 Nov; 60(11):700-9. PubMed ID: 5381650
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurosurgical treatment of pyramidal and extrapyramidal motor disorders].
    KROLL FW
    Ther Ggw; 1952 Feb; 91(2):41-4. PubMed ID: 14922341
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced extrapyramidal symptoms. A cooperative study.
    JAMA; 1973 May; 224(6):889-91. PubMed ID: 4144552
    [No Abstract]   [Full Text] [Related]  

  • 13. Flupenthixol and trifluoperazine: a double-blind investigation in the treatment of schizophrenics.
    Gottfries CG
    Br J Psychiatry; 1971 Nov; 119(552):547-8. PubMed ID: 4944664
    [No Abstract]   [Full Text] [Related]  

  • 14. [The late result of surgery of extrapyramidal movement disorders and paraplegias].
    SCHURMANN K
    Dtsch Z Nervenheilkd; 1952; 169(1):24-8. PubMed ID: 13020628
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON THE DIAGNOSIS AND DIFFERENTIAL DIAGNOSIS OF CEREBRAL POLIOMYELITIS WITH PYRAMIDAL AND EXTRAPYRAMIDAL DISORDERS].
    HUFFMANN G
    Med Welt; 1964 Oct; 44():2368-73. PubMed ID: 14333777
    [No Abstract]   [Full Text] [Related]  

  • 16. The extrapyramidal systems of the spinal cord. II. Results of combined pyramidal and extrapyramidal lesions in the macaque.
    Goldberger ME
    J Comp Neurol; 1969 Jan; 135(1):1-26. PubMed ID: 4976339
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effectiveness of gamma-OH in muscular hypertonus of extrapyramidal and pyramidal origin].
    Fera L
    Acta Neurol (Napoli); 1975; 30(3):243-7. PubMed ID: 1163325
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE CLINICAL ASPECTS AND THERAPY OF PYRAMIDAL AND EXTRAPYRAMIDAL MOVEMENT DISORDERS].
    RETT A
    Wien Klin Wochenschr; 1963 Oct; 75():772-5. PubMed ID: 14093592
    [No Abstract]   [Full Text] [Related]  

  • 19. Action of L-Dopa in drug induced extrapyramidalism.
    Yaryura-Tobias JA; Wolpert A; Dana L; Merlis S
    Dis Nerv Syst; 1970 Jan; 31(1):60-3. PubMed ID: 5413729
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extrapyramidal movement disorders following administration of flunarizine].
    Jongerius AM; van Gool AR
    Ned Tijdschr Geneeskd; 1989 Apr; 133(14):746-7. PubMed ID: 2716906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.